<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: panitumumab</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Adding drug to chemotherapy following colon cancer surgery does not improve disease-free survival</title>
   	 <description>Adding the drug cetuximab to a regimen of drugs used for the treatment of patients following surgery for stage III colon cancer did not result in improved disease-free survival, according to a study in the April 4 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-04-adding-drug-chemotherapy-colon-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 03 Apr 2012 16:02:50 EST</pubDate>
	 <guid isPermaLink="false">news252687759</guid>
	 
</item>
<item>
     <title>Study identifies a cause of resistance to colon cancer treatment</title>
   	 <description>Doctors and researchers of Hospital del Mar and its research institute, the IMIM, have lead a study describing a new pharmacological resistance to cancer. This new mechanism is a mutation in an oncogene called EGFR (epidermal growth factor receptor) causing resistance to treatment using a drug called cetuximab, a monoclonal antibody which specifically attacks the EGFR.</description>
     <link>http://medicalxpress.com/news/2012-01-resistance-colon-cancer-treatment.html</link>
	 <category>Cancer</category>
	 <pubDate>Sun, 22 Jan 2012 13:04:32 EST</pubDate>
	 <guid isPermaLink="false">news246459858</guid>
	 
</item>


</channel>
</rss>
